Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome

    Yuanqing Wang2,3, Jianye Yan2, Shunxiang Li2★, Xiong Cai4, Wei Wang5, Kun Luo2, Dan Huang2, Jiesheng Gao6★ Corresponding author

    1. 1Departments of Chemistry, Key Laboratory of Modernization of Chinese Medicine, China.
    2. 2Department of Biotechnology, Laboratory of Biotechnology and Engineering, School of Life Science and Technology, Central South University of Forestry and Technology, China.
    3. 3Department of Diagnosis, Diagnostic Institute of Traditional Chinese Medicine, Hunan University of Chinese Medicine, China.
    4. 4TCM and Ethnomedicine Innovation and Development Laboratory, School of Pharmacy, China.
    5. 5Department of Rheumatism and Immunology, Xiangya Second Hospital of Central South University, Changsha, China.

    CORRESPONDENCE

    Shunxiang Li

    Department of Biotechnology, Laboratory of Biotechnology and Engineering, School of Life Science and Technology, Central South University of Forestry and Technology, China.

    lishunxiang@hotmail.com

    Received: 30-07-2013; Revised: 22-08-2013.

    Volume 10, Issue 39 · pp. 285–291 · PUBLISHED 24 July 2014 · DOI: 10.4103/0973-1296.137369

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Bushen Huoxue Qubi (BHQ) granules, a traditional Chinese medicine preparation, has been clinically used for the treatment of the blood stasis syndrome. Objective: The main objective is to investigate whether the diseased condition would alter the pharmacokinetics and tissue distribution of tanshinone IIA in BHQ, which was given orally to the acute blood stasis rats. Materials and Methods: The main bioactive constituent in BHQ, tanshinone IIA, was measured in the plasma and tissues of animals by the high performance liquid chromatography with ultraviolet detection. The analysis was successfully performed on an Agilent TC‑C18 column (250 × 4.6 mm I.D., 5 μm) protected with a Octadecylsilane (ODS) guard column (10 × 4.6 mm I.D., 5 μm). The mobile phase was aqueous solution (A) (containing 0.40% aqueous acetic acid) and acetonitrile (B). The conditions of the solvent gradient elution were 35‑40% (B) in 0‑15 min, 40‑42% (B) in 15‑18 min and 42‑70% (B) in 18‑30 min at a flow rate of 1.0 mL/min. Detection was conducted with wavelength of 270 nm at 30°C. Results: Good linearity relationships were found (r2 > 0.9955) over the investigated concentration range for bio‑samples. Blood stasis was associated with significantly higher area under the concentration‑time curve (AUC), the maximum plasma concentration (Cmax) and biological half‑life (t1/2), lower total body clearance (CL) and apparent volume of distribution (Vd) of tanshinone IIA in plasma and higher AUC0‑t of tanshinone IIA in the analyzed tissues of rats treated with BHQ. Conclusion: Blood stasis could alter pharmacokinetics and tissue distribution of tanshinone IIA in BHQ.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Wang, Y., Yan, J., Li, S., Cai, X., Wang, W., Luo, K., Huang, D., & Gao, J. (2014). Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome. Pharmacognosy Magazine, 10(39), 285–291. https://doi.org/10.4103/0973-1296.137369